Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Kahn

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Neuropathology and Applied Neurobiology|October 1, 1993
Neurological reactions in HIV-infected patients treated with trichosanthinP A Garcia, D E Bredesen, H V Vinters, et al.
Annals of Internal Medicine|March 15, 1995
Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working GroupR T D'Aquila, V A Johnson, S L Welles, et al.
AIDS (London, England)|April 13, 2004
Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behaviorJeffrey N Martin, Michelle E Roland, Torsten B Neilands, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2001
Prototype trial design for rapid dose selection of antiretroviral drugs: an example using emtricitabine (Coviracil)F S Rousseau, J O Kahn, M Thompson, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adultsP Barditch-Crovo, S G Deeks, A Collier, et al.
Blood|May 1, 2004
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral loadSteven G Deeks, Christina M R Kitchen, Lea Liu, et al.
The Journal of Infectious Diseases|June 25, 2004
Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infectionJason D Barbour, Frederick M Hecht, Terri Wrin, et al.
AIDS Research and Human Retroviruses|April 12, 2003
Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine, and nelfinavir before complete HIV type 1 seroconversionDon E Smith, Gilbert R Kaufmann, James O Kahn, et al.
JAMA|July 11, 1998
New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposesR S Janssen, G A Satten, S L Stramer, et al.
Journal of Cardiothoracic and Vascular Anesthesia|September 12, 2025
ECMO in Pregnancy: Analysis of Indications, Management and OutcomesJuan G Ripoll, Yul O Kahn-Pascual, Troy G Seelhammer, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Neuropathology and Applied Neurobiology|October 1, 1993
Neurological reactions in HIV-infected patients treated with trichosanthinP A Garcia, D E Bredesen, H V Vinters, et al.
Annals of Internal Medicine|March 15, 1995
Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working GroupR T D'Aquila, V A Johnson, S L Welles, et al.
AIDS (London, England)|April 13, 2004
Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behaviorJeffrey N Martin, Michelle E Roland, Torsten B Neilands, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2001
Prototype trial design for rapid dose selection of antiretroviral drugs: an example using emtricitabine (Coviracil)F S Rousseau, J O Kahn, M Thompson, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adultsP Barditch-Crovo, S G Deeks, A Collier, et al.
Blood|May 1, 2004
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral loadSteven G Deeks, Christina M R Kitchen, Lea Liu, et al.
The Journal of Infectious Diseases|June 25, 2004
Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infectionJason D Barbour, Frederick M Hecht, Terri Wrin, et al.
AIDS Research and Human Retroviruses|April 12, 2003
Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine, and nelfinavir before complete HIV type 1 seroconversionDon E Smith, Gilbert R Kaufmann, James O Kahn, et al.
JAMA|July 11, 1998
New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposesR S Janssen, G A Satten, S L Stramer, et al.
Journal of Cardiothoracic and Vascular Anesthesia|September 12, 2025
ECMO in Pregnancy: Analysis of Indications, Management and OutcomesJuan G Ripoll, Yul O Kahn-Pascual, Troy G Seelhammer, et al.
Pageof 9